What is the Illumiscreen prenatal test?
The Illumiscreen prenatal test is a simple blood test that screens for the most common chromosomal abnormalities that can affect your baby’s future health (Trisomy 21 – Down syndrome, Trisomy 18 – Edwards syndrome, Trisomy 13 – Patau syndrome and sex aneuploides). It can also provide gender information if you wish.
A sample can be drawn in your doctor’s office as early as the tenth week of pregnancy. It may help you avoid more invasive procedures, such as amniocentesis or chorionic villus sampling (CVS), which can pose risks to you and your baby. The Illumiscreen test is available for both singleton and twin pregnancies.
Why should I choose the Illumiscreen test
over other tests?
The Illumiscreen test sheds much-needed light on the chromosomal health of your unborn baby—providing the reassurance of reliable answers no other screening test can. Compared to similar options, the Illumiscreen prenatal test offers accurate information, rather than calculating chances or risk scores. In addition, it does not carry the risk of complications that invasive procedures do.
What does it cost?
Currently, this testing is not covered under the community contract for funded pathology testing services and does incur a cost of $615.
There will also be an additional fee to collect the sample which can vary depending on which service provider you use.
- A simple, in-office blood test
- Safe from procedural risks of invasive procedures (amniocentesis/CVS)
- Lowest test failure rate among noninvasive prenatal tests
- Fast results – usually sent to the laboratory in 5-7 business days after sample receipt